Company intelligence / Profile preview

SMART Brain Aging

Phoenix, Arizona, United Statessmartbrain.io ↗

Ownership: Private
Development stage: Commercial

Overview

SMART Brain Aging delivers evidence-based digital programs designed to reduce cognitive decline in older adults. The company’s offerings are grounded in over seven years of dementia research and have been developed with input from clinical neuropsychologists. Programs are available commercially, both virtually and onsite, targeting elderly populations at risk for dementia or experiencing early signs of cognitive impairment.

Therapeutic areas: Neurology
Modalities: Non-pharmacological therapyDigital therapeutic program
Industry: Digital Health Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships disclosed as of current information.

Beyond the preview

Go deeper on SMART Brain Aging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMART Brain Aging.

Explore the full profile